AstraZeneca: FDA Committee Recommends Nirsevimab For RSV Low

LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN, AZN.L) announced Friday that the US Food and Drug Administration Antimicrobial Drugs Advisory Committee or AMDAC has unanimously recommended

Related Keywords

United Kingdom , Zeiten , Mecklenburg Vorpommern , Germany , London , City Of , British , Stefan Klotter , Astrazeneca Plc , Astrazeneca , Centers For Disease , Drug Administration Antimicrobial Drugs Advisory Committee , More Such Health News , Disease Control , Biologics License Application , Prescription Drug User Fee Act , Stabile Ertr , Chart Profi Stefan Klotter , Blue Chips , Committee , Ecommends , Nirsevimab , Tower , Espiratory , Tract , Disease , Infants ,